In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefatrizine Drug Master File in Korea (Cefatrizine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefatrizine. The MFDS reviews the Cefatrizine KDMF as part of the drug registration process and uses the information provided in the Cefatrizine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefatrizine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefatrizine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefatrizine suppliers with KDMF on PharmaCompass.